ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma

Zou, Yiping; Ruan, Shiye; Jin, Liang; Chen, Zhihong; Han, Hongwei; Zhang, Yuanpeng; Jian, Zhixiang; Lin, Ye; Shi, Ning*; Jin, Haosheng*广东省人民医院; 汕头大学
MEDICAL SCIENCE MONITOR2020-8-31DOI: 10.12659/MSM.925289
60被引9阅读
引用收藏
分享

摘要

Background: Orderly G2/M transition in the cell cycle is controlled by the cyclin-dependent kinase 1/cyclin B (CDK1/CCNB) complex. We aimed to comprehensively investigate the roles of CDK1, CCNB1, and CCNB2 via multi-omits analysis and their relationships with immune infiltration in hepatocellular carcinoma (HCC). @@@ Material/Methods: The transcriptional data and the epigenetic and genetic alterations of CDK1, CCNB1, and CCNB2, as well as their impacts on prognosis in HCC patients, were identified using multiple databases. The correlations between expression of these genes and immune infiltration in HCC were then explored using the TIMER database. @@@ Results: Overall, mRNA expression of CDK1, CCNB1, and CCNB2 was up-regulated in various tumor tissues including HCC. Higher expression of these genes was associated with poorer prognosis in HCC patients. Lower promoter methylation of these genes might cause higher expression levels in tumor tissues of HCC. Genetic alterations and several methylated-CpG sites in these genes were significantly associated with survival. Notably, expression levels of CDK1, CCNB1, and CCNB2 were positively correlated with infiltrating levels of CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells in HCC. In addition, significant correlations between the expression of these genes and various immune markers in HCC, such as PD-1, PDL-1, and CTLA-4, were also observed. @@@ Conclusions: CDK1, CCNB1, and CCNB2 are potential prognostic biomarkers and associated with immune cell infiltration in HCC. The genes may be utilized to predict the reaction of immunotherapy. Combining inhibitors of these genes with immunotherapy may improve the survival time of HCC patients.

学科与关键词

关键词
Biological MarkersCarcinoma, HepatocellularCDC2 Protein KinaseTumor Escape
相关
加载中…
  • High expression of CCDC6 in relation to unfavorable outcome and immune cells infiltration in hepatobiliary carcinoma
    Wu, Tianyu; Jiang, Xiaoqing; Xu, Bin; Zhong, Quan; Zheng, Jinsheng; Zhang, Xin*; Wang, Yu*American Journal of Cancer Research, 2022, 13(12): 3378-3395.被引 3
  • G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
    Wang, Hang; Yu, Liang; Cui, Yunfu*; Huang, Jiaxin*DISEASE MARKERS, 2022, 2022: 1313359.被引 4
  • Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment
    Yin, Zi*; Ma, Tingting; Chen, Sheng; Yu, Min*Cancer Biomarkers, 2023, 36(3): 231-250.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
MEDICAL SCIENCE MONITOR
发表日期
2020-08-31
卷期
第 26 卷
页码
e925289
DOI
10.12659/MSM.925289
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong [c17140500000053]; Natural Science Foundation of China [81972792]

作者

  • Z

    Zou, Yiping (第一作者)

    guangdong prov peoples hosp · shantou univ

  • R

    Ruan, Shiye

    guangdong prov peoples hosp

查看全部 10 位作者收起作者
  • J

    Jin, Liang

    guangdong prov peoples hosp

  • C

    Chen, Zhihong

    guangdong prov peoples hosp

  • H

    Han, Hongwei

    guangdong prov peoples hosp

  • Z

    Zhang, Yuanpeng

    guangdong prov peoples hosp

  • J

    Jian, Zhixiang

    guangdong prov peoples hosp

  • L

    Lin, Ye

    guangdong prov peoples hosp

  • S

    Shi, Ning (通讯)

    guangdong prov peoples hosp

  • J

    Jin, Haosheng (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417